Australian Clinical Labs (ASX:ACL) Construction In Progress : A$0.0 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs Construction In Progress?

Australian Clinical Labs's quarterly construction in progress increased from Dec. 2022 (A$0.0 Mil) to Jun. 2023 (A$1.7 Mil) but then declined from Jun. 2023 (A$1.7 Mil) to Dec. 2023 (A$0.0 Mil).

Australian Clinical Labs's annual construction in progress increased from Jun. 2021 (A$1.7 Mil) to Jun. 2022 (A$3.3 Mil) but then declined from Jun. 2022 (A$3.3 Mil) to Jun. 2023 (A$1.7 Mil).

Australian Clinical Labs Construction In Progress Historical Data

The historical data trend for Australian Clinical Labs's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs Construction In Progress Chart

Australian Clinical Labs Annual Data

Trend

Dec20

Jun21

Jun22

Jun23

Construction In Progress

1.69

3.35

1.69

Australian Clinical Labs Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Construction In Progress	Get a 7-Day Free Trial			-	3.35	-	1.69	-

Australian Clinical Labs Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Australian Clinical Labs (ASX:ACL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

N/A

Address

1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168

Website

https://www.clinicallabs.com.au

Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.

Australian Clinical Labs (ASX:ACL) Headlines

No Headlines